Jim Carroll keynote for PhRMA

PhRMA brought me in to examine the acceleration of healthcare in what I described as an era of exponentiation.

The pharmaceutical industry was operating inside an extraordinary period of scientific change.

Genomics was accelerating.

Medical knowledge was expanding.

Personalized medicine was becoming more practical.

New therapeutic approaches were emerging.

And digital technologies were beginning to reshape research, treatment and the patient relationship.

The core message was simple.

The future of pharma would not be shaped only by the next discovery.

It would be shaped by the fact that discovery was occurring faster.

Pharma was entering the era of exponentiation — where the rate of scientific progress becomes a strategic force in its own right.